Adelman D - Search Results

1

Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.

Gordon MS, Margolin K, Talpaz M, Sledge GW Jr, Holmgren E, Benjamin R, Stalter S, Shak S, Adelman D. Gordon MS, et al. Among authors: adelman d. J Clin Oncol. 2001 Feb 1;19(3):843-50. doi: 10.1200/JCO.2001.19.3.843. J Clin Oncol. 2001. PMID: 11157038 Clinical Trial.

2

Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data.

Margolin K, Gordon MS, Holmgren E, Gaudreault J, Novotny W, Fyfe G, Adelman D, Stalter S, Breed J. Margolin K, et al. Among authors: adelman d. J Clin Oncol. 2001 Feb 1;19(3):851-6. doi: 10.1200/JCO.2001.19.3.851. J Clin Oncol. 2001. PMID: 11157039 Clinical Trial.

3

Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules.

Advani RH, Hurwitz HI, Gordon MS, Ebbinghaus SW, Mendelson DS, Wakelee HA, Hoch U, Silverman JA, Havrilla NA, Berman CJ, Fox JA, Allen RS, Adelman DC. Advani RH, et al. Clin Cancer Res. 2010 Apr 1;16(7):2167-75. doi: 10.1158/1078-0432.CCR-09-2236. Epub 2010 Mar 16. Clin Cancer Res. 2010. PMID: 20233886 Clinical Trial.

4

A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors.

Heath EI, Bible K, Martell RE, Adelman DC, Lorusso PM. Heath EI, et al. Invest New Drugs. 2008 Feb;26(1):59-65. doi: 10.1007/s10637-007-9090-3. Epub 2007 Oct 16. Invest New Drugs. 2008. PMID: 17938863 Clinical Trial.

5

Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy.

Corren J, Shapiro G, Reimann J, Deniz Y, Wong D, Adelman D, Togias A. Corren J, et al. Among authors: adelman d. J Allergy Clin Immunol. 2008 Feb;121(2):506-11. doi: 10.1016/j.jaci.2007.11.026. J Allergy Clin Immunol. 2008. PMID: 18269927 Clinical Trial.

6

Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin).

Rockson SG, Kramer P, Razavi M, Szuba A, Filardo S, Fitzgerald P, Cooke JP, Yousuf S, DeVault AR, Renschler MF, Adelman DC. Rockson SG, et al. Among authors: adelman dc. Circulation. 2000 Nov 7;102(19):2322-4. doi: 10.1161/01.cir.102.19.2322. Circulation. 2000. PMID: 11067782 Clinical Trial.

7

Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer.

Krug LM, Crawford J, Ettinger DS, Shapiro GI, Spigel D, Reiman T, Temel JS, Michelson GC, Young DY, Hoch U, Adelman DC. Krug LM, et al. Among authors: adelman dc. J Thorac Oncol. 2011 Feb;6(2):384-6. doi: 10.1097/JTO.0b013e318200e509. J Thorac Oncol. 2011. PMID: 21252718 Free article. Clinical Trial.

8

Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis.

Casale TB, Bernstein IL, Busse WW, LaForce CF, Tinkelman DG, Stoltz RR, Dockhorn RJ, Reimann J, Su JQ, Fick RB Jr, Adelman DC. Casale TB, et al. Among authors: adelman dc. J Allergy Clin Immunol. 1997 Jul;100(1):110-21. doi: 10.1016/s0091-6749(97)70202-1. J Allergy Clin Immunol. 1997. PMID: 9257795 Clinical Trial.

9

Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.

Corren J, Diaz-Sanchez D, Saxon A, Deniz Y, Reimann J, Sinclair D, Davancaze T, Adelman D. Corren J, et al. Among authors: adelman d. Ann Allergy Asthma Immunol. 2004 Sep;93(3):243-8. doi: 10.1016/S1081-1206(10)61495-0. Ann Allergy Asthma Immunol. 2004. PMID: 15478383 Clinical Trial.

10

Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy.

Chinthrajah RS, Jones SM, Kim EH, Sicherer SH, Shreffler W, Lanser BJ, Atri N, Babineau DC, Adelman DC, Iqbal A, Limb SL, Rudman Spergel AK, Togias A, Wood RA. Chinthrajah RS, et al. J Allergy Clin Immunol. 2022 Jun;149(6):2166-2170.e1. doi: 10.1016/j.jaci.2021.12.789. Epub 2022 Jan 11. J Allergy Clin Immunol. 2022. PMID: 35026206 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters